Accelerated review, approval, and access procedures that more efficiently address unmet patient needs have challenging consequences for the regulatory and technical aspects of drug development. This complexity increases the need for clearly communicating harmonized regulatory and technical standards through forums, such as those generated by DIA.
Learning
DIA Digital Learning Catalog
DIA Learning programs provide unique, realistic opportunities for professionals to learn best practices in their fields with Internet-based courseware, conveniently accessible anytime, anywhere.
Good Clinical Practices & QA Community
Members of our Community enjoy a professional, neutral forum for discussing issues and sharing medical, scientific, and regulatory information related to Good Clinical Practices (GCP) in Phase I-IV Clinical Trials.